NurseJet
Back to Discover
Research ArticleResearchPatient EducationMedication Safety

Probiotic VSL#3 did not improve juvenile arthritis activity in a small trial

Gut microbes (PubMed)Sep 10, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A multicenter double-blind randomized trial found that three months of VSL#3 probiotic supplementation did not improve the primary clinical response outcome in children with oligoarticular or rheumatoid-factor-negative polyarticular juvenile idiopathic arthritis.

What NurseJet pulled from the source

Forty-four children received VSL#3 or placebo in addition to standard therapy. ACR Pedi 30 response occurred in 47% with VSL#3 and 63% with placebo (p=0.33), while a conservative analysis for missing data favored placebo.

Why this matters for nurses

Families may view probiotics as low-risk add-ons for autoimmune disease. This small trial did not show clinical benefit and identified a change in innate immune signaling that the authors say warrants careful evaluation.

Bedside takeaway

Do not substitute probiotics for standard JIA therapy; this small trial found no clinical-response benefit.

Key takeaways

  • Probiotic supplementation increased fecal Toll-like receptor 4 agonist activity.
  • Gut-microbiota diversity, intestinal permeability, and systemic cytokine levels did not change detectably.
  • The mechanistic change did not translate into improved disease activity during the three-month intervention.

Practice implications

  • Ask about supplement use, avoid presenting probiotics as a substitute for disease-modifying therapy, and reinforce the prescribed pediatric rheumatology plan.

Limitations & cautions

  • Abstract-only summary. The trial enrolled 44 children, lasted three months, included selected juvenile-arthritis subtypes, and had missing-data sensitivity results that increased uncertainty.
  • AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Gut microbes (PubMed)

Gut microbes (PubMed). Probiotic supplementation increases fecal TLR4 agonists without improving disease activity in juvenile idiopathic arthritis: a randomized placebo-controlled trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42720258/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Critical care medicine (PubMed)

A randomized controlled trial of 100 adult ICU patients undergoing ventilator weaning found that daily individualized 25-minute music therapy significantly improved RASS sedation scores, reduced propofol requirements, and reduced tracheostomy rates by 14%.

ICUMed-SurgAI summaryReview source

International journal of nursing studies (PubMed)

A systematic review and per-unit linear meta-analysis across 13 observational studies of 3,831,327 hospitalized adults found that each additional patient assigned per nurse was associated with a 5.7% increase in the odds of 30-day all-cause mortality.

LeadershipMed-SurgAI summaryReview source

International journal of nursing studies advances (PubMed)

A systematic review of five randomized controlled trials in adult patients found that non-nebulized topical lidocaine provides strong evidence for pain reduction and moderate evidence for easing discomfort and cough during nasogastric tube insertion.

Med-SurgEmergencyAI summaryReview source